Cdc7 kinase inhibitors and uses thereof

Details for Australian Patent Application No. 2011224457 (hide)

Owner Sloan-Kettering Institute for Cancer Research

Inventors Frattini, Mark G.; Djaballah, Hakim; Kelly, Thomas J.

Agent Davies Collison Cave

Pub. Number AU-A-2011224457

PCT Pub. Number WO2011/112635

Priority 61/311,741 08.03.10 US

Filing date 8 March 2011

Wipo publication date 15 September 2011

International Classifications

A61K 31/122 - having the oxygen atom directly attached to a ring, e.g. quinones, vitamin K, anthralin

A61P 35/00 Antineoplastic agents

Event Publications

20 September 2012 PCT application entered the National Phase

  PCT publication WO2011/112635 Priority application(s): WO2011/112635

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011224464-Laminate film for attaching to a window

2011224454-Secondary reflector for Linear Fresnel Reflector system